Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.
The role of Plk3 in oncogenesis
The oncogene ERG: a key factor in prostate cancer
Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma
HUS1 regulates in vivo responses to genotoxic chemotherapies
Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability
Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression
Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis
A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses
ELAS1-mediated inhibition of the cyclin G1–B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53
Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma
An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors
Send Us Feedback
Are we missing a journal?
Would you like to see changes on these pages?
email us your feedback...
Event Support and Materials
Pipelines in Oncology
The Cancer Letter
Maps, Directions, and Shuttles